- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Roswell Park Comprehensive Cancer Center | Strategic Alliance Partners
Latest from Roswell Park Comprehensive Cancer Center
Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias
December 20, 2024
Article
A preclinical study showed gilteritinib can strengthen CAR T-cell therapy in two high-risk pediatric leukemias.
Roswell Park Experts Present Evidence to Help Clinicians Advise Breast Cancer Survivors About Lifestyle Choices
December 16, 2024
Article
Sessions at San Antonio Breast Cancer Symposium address exercise, cannabis, sexual health, plus insights on treatment.
Recapping the Latest in AML With Dr Eunice Wang
December 08, 2024
Video
Eunice Wang, MD, of Roswell Park Comprehensive Cancer Center, sits down with Chandler Park, MD, FACP, to discuss the latest in acute myeloid leukemia from the 2024 ASH Annual Meeting.
Tomorrow’s Promise, Today’s Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment
December 05, 2024
Article
Roswell Park CEO Candace S. Johnson, PhD, introduces center’s first Physician in Chief, leaders in strategic areas
Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer
November 28, 2024
Article
A treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with TNBC.
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
November 25, 2024
Article
More than a dozen teams to share advances in blood cancer treatment and research innovations at the 2024 ASH Annual Meeting.
Roswell Park Team Members Recognized for Exceptional Support to First Responders
November 19, 2024
Article
Nurse-executive and partnership manager honored for dedication to local heroes.
Obinutuzumab and Liso-Cel Revisions to CLL/SLL NCCN Guidelines Mark Most Notable Changes of 2024
November 06, 2024
Article
Matthew Cortese, MD, MPH, details 2024/2025 updates to the NCCN guidelines for CLL/SLL and treatments to look forward to in the future.
New Computational Method Links One Mammal’s Striking Longevity and Resistance to Cancer With ‘Dark Genome’
October 30, 2024
Article
A Roswell Park study reveals the evolutionary stability of the naked mole-rat’s genome, and implications for drug development.
Roswell Park Radiation Oncologist Highlights New Insights on Single-Fraction Radiation for Central Lung Tumors
October 16, 2024
Article
Study featured at ASTRO 2024 is one of the first to assess single-fraction SBRT for centrally located lung cancers
Dr Hernandez-Ilizaliturri on Selecting Between CAR T-Cell Therapies for FL
October 11, 2024
Video
Francisco Hernandez-Ilizaliturri, MD, discusses factors that inform the selection of CAR T-cell therapies for patients with follicular lymphoma.
Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia
October 11, 2024
Article
Roswell Park’s Dr. Eunice Wang led KOMET-001 clinical trial; results newly reported in The Lancet Oncology.
Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals
September 24, 2024
Article
Black patients and older adults are least likely to undergo this treatment for blood cancers and hematologic disorders.
Dr McCarthy on Neutrophil Activity in Multiple Myeloma
August 30, 2024
Video
Philip McCarthy, MD, discusses a study of neutrophil gene signatures within focal lesions that are linked to progression-free survival in multiple myeloma.
Roswell Park Again Named a Top 10 New York State Employer by Forbes
August 30, 2024
Article
Third year in a row cancer center has been ranked on this listing, based on employee surveys.
CDK4/6 Inhibitors, ADCs, and PI3K Inhibitors Individualize HR+ Breast Cancer Management
August 26, 2024
Article
Shipra Gandhi, MD, discusses the evolution of CDK4/6 inhibitors and ADCs across breast cancer subtypes.
Final Results of Phase 2 Clinical Trial Clarify Role of JAK2 Inhibitor in Combating Acute Graft-Versus-Host Disease
August 23, 2024
Article
A study demonstrates that adding a JAK2 inhibitor to standard immunosuppressive drugs does not improve prevention of acute graft-versus-host disease.
The HR-Positive Breast Cancer Treatment Paradigm Sits on the Cusp of Significant Shifts
August 22, 2024
Article
Shipra Gandhi, MD, highlights findings with oral SERDs in HR-positive breast cancer and options to consider after progression on CDK4/6 inhibitors.
Dr Hernandez-Ilizaliturri on the Use of CAR T-Cell Therapy in R/R Multiple Myeloma
August 19, 2024
Video
Francisco Hernandez-Ilizaliturri, MD, discusses the use of CAR T-cell therapy in patients with relapsed/refractory multiple myeloma.